Zalicus Inc. (ZLCS) President and CEO to Ring The NASDAQ Stock Market Closing Bell

ADVISORY, Sept. 16, 2010 (GLOBE NEWSWIRE) --

What:

Mark Corrigan, President and CEO of Zalicus Inc. (ZLCS), will visit NASDAQ MarketSite in Times Square and preside over the NASDAQ Closing Bell. The Company's common stock began trading on the NASDAQ Global Market on Thursday, September 9, 2010 under the ticker symbol ZLCS.  

Where:

NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Friday, September 17, 2010 at 3:50 p.m.- 4:00 p.m. ET 

Contact:

Justin Renz 

Senior Vice President, CFO  

Zalicus Inc.  

617-301-7575  

JRenz@zalicus.com

Gina Nugent

857-753-6562 

gnugent@zalicus.com

NASDAQ MarketSite:

Jolene Libretto

(646) 441-5220

Jolene.Libretto@NASDAQOMX.com

Feed Information:

The Closing Bell feed is available from 3:50 p.m. to 4:05 p.m. ET on AMC-3/C-3 (ul 5985V; dl 3760H). The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Jolene Libretto (646) 441-5220.

Radio Feed:

An audio transmission of the Closing Bell feed is also available from 3:50 p.m. to 4:05 p.m. ET on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Facebook and Twitter

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

http://www.facebook.com/pages/NASDAQ-OMX/108167527653

For news tweets, please visit our Twitter page at:

http://twitter.com/nasdaqomx

Webcast:

A live webcast of the NASDAQ Closing Bell will be available at:

http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.                        

About Zalicus:

Zalicus Inc. (Nasdaq:ZLCS) is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Zalicus applies its selective ion-channel modulation platform and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators. To learn more about Zalicus, please visit www.zalicus.com.

About NASDAQ OMX:

The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. *Please follow NASDAQ OMX on Facebook (http://www.facebook.com/pages/NASDAQ-OMX/108167527653) and Twitter (http://www.twitter.com/nasdaqomx).

NDAQA

In This Story

NDAQ